Pfizer Inc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$238.8M
Q ending 2026-03-31
Prior quarter
$236.5M
Q ending 2025-12-31
Change
+1.0% QoQ · -52.3% YoY
Positions
18
reported holdings
Largest positions
All 18 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Oric Pharmaceuticals Inc | ORIC | Shares | $57.7M | 4.8M |
| Allogene Therapeutics Inc | ALLO | Shares | $49.8M | 22.0M |
| Arvinas Inc | ARVN | Shares | $34.9M | 3.5M |
| Celcuity Inc | CELC | Shares | $31.3M | 296K |
| Zura Bio Ltd | Shares | $16.8M | 2.8M | |
| Wave Life Sciences Ltd | Shares | $11.9M | 1.9M | |
| Pyxis Oncology Inc | PYXS | Shares | $9.2M | 7.0M |
| Caribou Biosciences Inc | CRBU | Shares | $8.3M | 4.7M |
| Spero Therapeutics Inc | SPRO | Shares | $5.5M | 2.4M |
| Biohaven Ltd | Shares | $4.2M | 506K | |
| Cardiff Oncology Inc | CRDF | Shares | $3.7M | 2.4M |
| Zentalis Pharmaceuticals Inc | ZNTL | Shares | $2.0M | 954K |
| Nextcure Inc | NXTC | Shares | $1.5M | 153K |
| Agomab Therapeutics Nv | AGMB | Shares | $814K | 75K |
| Q32 Bio Inc | QTTB | Shares | $737K | 102K |
| Bolt Biotherapeutics Inc | BOLT | Shares | $137K | 31K |
| Ginkgo Bioworks Holdings Inc | DNA | Shares | $17K | 3K |
| Senseonics Hldgs Inc | SENS1GBP | Shares | $14K | 2K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.